Abeona Therapeutics Announces DSMB Approves Dose Escalation for Second Cohort in Phase 1/2 Clinical Trial for Sanfilippo Syndrome Type A

News

Abeona Therapeutics logo

Abeona Therapeutics Announces DSMB Approves Dose Escalation for Second Cohort in Phase 1/2 Clinical Trial for Sanfilippo Syndrome Type A

The Data Safety Monitoring Board, a collection of experts in the medical field who are independent of Nationwide Children’s Hospital and Abeona Therapeutics, has reviewed the data and test results, gathered from the first three children enrolled in the clinical

National Draw emblem

National Draw

It’s that time of the year again where the festive season of giving is nearing us and we are all making plans to spend time with our friends, family and loved ones. This time of the year also means that

Expert and patient meeting on Maroteux Lamy Disease (MPS VI) 15 to 16 October

Programme for MPS VI meeting announced

The line up for the expert and patient meeting on Maroteaux Lamy Disease (MPS VI) has been announced and is now open for bookings. This is the first time a meeting dedicated to MPS VI has been held by the Society for

Lysogene logo

Lysogene launches a prospective, observational study of MPS IIIA

Lysogene has launched a prospective, observational study of patients, who are aged nine years old or younger, with mucopolysaccharidosis IIIA (MPS IIIA) to better understand their health problems and how to measure these problems over time. This is an observational

Drayton Manor Family Weekend

The MPS Society is delighted to invite our families to join us for an exciting weekend at Drayton Manor Theme Park in Staffordshire, from Friday 5th to Sunday 7th August 2016. Priced at just £169 for a family of four,